This inventor holds 1 USPTO granted patent. Top assignee: Shionogi & Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Kotaro Nagatani: Innovator in Serotonin Receptor Research
Introduction
Kotaro Nagatani is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that interact with serotonin receptors. His work has implications for various therapeutic applications.
Latest Patents
Nagatani holds a patent for "Heteroaromatic derivatives having serotonin receptor binding activity." This patent includes compounds that exhibit serotonin 5-HT2A receptor inverse agonism, along with pharmaceutically acceptable salts and compositions comprising these compounds. His innovative work in this area is crucial for advancing treatments related to serotonin-related disorders.
Career Highlights
Nagatani is associated with Shionogi & Co., Ltd., a well-respected pharmaceutical company. His role at Shionogi has allowed him to focus on research and development in the field of medicinal chemistry. His expertise has contributed to the company's reputation for innovation in drug development.
Collaborations
Throughout his career, Nagatani has collaborated with notable colleagues, including Kenji Nakahara and Kouki Fuchino. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in their projects.
Conclusion
Kotaro Nagatani is a key figure in the realm of serotonin receptor research, with a patent that showcases his innovative approach to pharmacology. His work continues to influence the development of new therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile